DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ultrasound Guided Local Infiltration Analgesia for Hip Arthroscopy

Information source: Saint Francis Care
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Hip Injuries

Intervention: liposomal bupivacaine (Drug); Bupivacaine (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: Saint Francis Care

Official(s) and/or principal investigator(s):
Sanjay Sinha, MD, Principal Investigator, Affiliation: Saint Francis Hospital and Medical Center

Overall contact:
Sanjay Sinha, MD, Email: sanjaysinha@comcast.net


This study is being undertaken to compare the pain control using either bupivacaine versus liposomal bupivacaine. Liposomal bupivacaine can potentially provide pain relief lasting up to 72 hours while regular bupivacaine can provide pain relief up to 12 hours

Clinical Details

Official title: Comparison of Bupivacaine to Liposomal Bupivacaine for Ultrasound Guided Periarticular Hip Infiltration for Postoperative Analgesia After Hip Arthroscopy.

Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Primary outcome: Opioid consumption

Secondary outcome: Pain Scores

Detailed description: Patients undergoing hip arthroscopy experience moderate to severe postoperative pain. Effective pain control after surgery is an important component in the overall management of these patients. Good pain control encourages early participation in rehabilitation program, increases success of the surgery, and improves patient satisfaction. Typically, postoperative analgesia is provided to these patients either with nerve blocks or opioid medications. Both these methods provide good pain relief but nerve blocks are associated with weakness of lower extremity muscles which interferes with early ambulation and increase the risk of falls while narcotic medications increase the risk of nausea, vomiting, itching, constipation, ileus, urinary retention, sedation and respiratory depression.


Minimum age: 18 Years. Maximum age: 80 Years. Gender(s): Both.


Inclusion Criteria:

- Patients having hip arthroscopy

Exclusion Criteria:

- History of neurologic disease, neuropathy, diabetes

- Allergy to local anesthetic solution

- Chronic use of narcotics

- Inability to give consent/cooperate with study

- History of previous hip arthroscopy on the ipsilateral side

- Pregnancy

Locations and Contacts

Sanjay Sinha, MD, Email: sanjaysinha@comcast.net

Saint Francis Hospital and Medical Center, Hartford, Connecticut 06105, United States; Recruiting
Sanjay Sinha, MD, Email: sanjaysinha@comcast.net
Sanjay Sinha, MD, Principal Investigator
Additional Information

Starting date: July 2013
Last updated: March 16, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017